Zobrazeno 1 - 10
of 10
pro vyhledávání: ''
Publikováno v:
American Journal of Clinical Oncology
Supplemental Digital Content is available in the text.
Objective: We aim to develop and validate an effective nomogram prognostic model for patients with typical lung carcinoid tumors using a large patient cohort from the Surveillance, Epidemiol
Objective: We aim to develop and validate an effective nomogram prognostic model for patients with typical lung carcinoid tumors using a large patient cohort from the Surveillance, Epidemiol
Autor:
Panagiotis Sarantis, Maria Michelli, Dimitrios Schizas, Michalis V. Karamouzis, Stamatios Theoharis, Georgia Kyriakopoulou, Athanasios G. Papavassiliou, Ioanna Giannopoulou, Ilenia Chatziandreou, Evangelos Koustas, Angelica A. Saetta
Publikováno v:
American Journal of Clinical Oncology
Supplemental Digital Content is available in the text.
Objectives: Autophagy plays a dual role in tumorigenesis. In the initial stages, it promotes cell survival and suppresses carcinogenesis, whereas in cancer development, it induces cancer cel
Objectives: Autophagy plays a dual role in tumorigenesis. In the initial stages, it promotes cell survival and suppresses carcinogenesis, whereas in cancer development, it induces cancer cel
Publikováno v:
Medicine
This study assessed the association of sirtuin type 1 (SIRT1) and survivin expression with the clinicopathological features and survival of esophageal squamous cell carcinoma (ESCC) patients after concurrent chemoradiotherapy. SIRT1 and survivin prot
Autor:
Kendall Lee Stevinson, C. Lance Cowey, Jenny Black-Shinn, Jennifer Frytak, Scot Ebbinghaus, Frank Xiaoqing Liu, Marley Boyd
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
The programmed death-1 inhibitor pembrolizumab has demonstrated efficacy and safety in clinical trials for treating advanced (unresectable/metastatic) melanoma. We investigated the real-world utilization of pembrolizumab and associated patient outcom
Autor:
Joanna Mangana, Mirjam C. Naegeli, Marjam J. Barysch, Simone M. Goldinger, Ralph P. Braun, Anna L. Frauchiger, Daniel Franzen, Mirjana Urosevic-Maiwald, Jivko Kamarachev, Reinhard Dummer, Florentia Dimitriou
Publikováno v:
Melanoma Research
The development of cancer immunotherapy and targeted therapy has reached an important inflection point in the history of melanoma. Immune checkpoint inhibitors and kinase inhibitors are today's standard of care treatments in advanced melanoma patient
Autor:
I. Jolanda M. de Vries, Rutger H. T. Koornstra, Gerty Schreibelt, Harm Westdorp, Carl G. Figdor, Kalijn F. Bol, Cornelis J. A. Punt, Erik H.J.G. Aarntzen, Winald R. Gerritsen, Steve Boudewijns, Jeroen H A Creemers
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
Journal of Immunotherapy (1997), 39, 241-8
Journal of immunotherapy (Hagerstown, Md., 39(6), 241-248. Lippincott Williams and Wilkins
Journal of Immunotherapy (1997), 39, 6, pp. 241-8
Journal of Immunotherapy (1997), 39, 241-8
Journal of immunotherapy (Hagerstown, Md., 39(6), 241-248. Lippincott Williams and Wilkins
Journal of Immunotherapy (1997), 39, 6, pp. 241-8
Contains fulltext : 172741.pdf (Publisher’s version ) (Open Access) The purpose of this study was to determine the toxicity profile of dendritic cell (DC) vaccination in stage III and IV melanoma patients, and to evaluate whether there is a correla
Publikováno v:
Anti-Cancer Drugs
To observe drug-induced hepatotoxicity by long-term gefitinib administration in the treatment of non-small-cell lung cancer. The data of 101 patients with locally advanced or metastatic non-small-cell lung cancer, for which gefitinib had been used or
Autor:
Linda de Munck, Jacques C. de Graaf, Frank G A Jansman, Sabine Siesling, James E. Boers, Johan M. van Rooijen, Guusje M. Teeuwen
Publikováno v:
Anti-cancer drugs, 27(2), 127-132. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 27(2), 127-32. LIPPINCOTT WILLIAMS & WILKINS
Anti-Cancer Drugs, 27(2), 127-32. LIPPINCOTT WILLIAMS & WILKINS
The addition of trastuzumab to chemotherapy in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) prolongs overall survival (OS) in clinical trials. However, treatment patterns and survival in daily practice are u
Autor:
Charalambos Deliveliotis, Dimitra Molyva, Dionisios Mitropoulos, Athanasios Papatsoris, C. Kalofonos, Meletios A. Dimopoulos, Stavros D. Peroukidis, Ioannis Adamakis, Kimon Tzannis, Konstantinos Stravodimos, Vassiliki Pissanidou, Nikolaos Pistamaltzian, Georgia Milaki, Athanasios Dellis, Vasilis Karavasilis, Ioannis M. Varkarakis, Nikos Androulakis, Constantinos Constantinides, Ilias Athanasiadis, Iraklis Mitsogiannis, Aristotelis Bamias, Charalambos Andreadis
Publikováno v:
Anti-Cancer Drugs
Relapsed urothelial cancer represents an unmet medical need. Vinflunine is a third-generation antimicrotubuline inhibitor and is currently the only approved drug for second-line treatment across the European Union. We conducted a retrospective analys
Metformin use has been associated previously with a decreased risk of cancer, but its association with renal cell carcinoma has not yet been investigated in observational studies. We aimed to explore the association between the use of metformin and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de8230e011ab080c40583d0abf8c37c
https://edoc.unibas.ch/52433/
https://edoc.unibas.ch/52433/